share_log

There's No Escaping Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.'s (SZSE:002223) Muted Earnings

江蘇裕越醫療器械及用品股份有限公司(SZSE:002223)の業績減少を回避することは不可能です。

Simply Wall St ·  07/28 20:22

With a price-to-earnings (or "P/E") ratio of 16.1x Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SZSE:002223) may be sending bullish signals at the moment, given that almost half of all companies in China have P/E ratios greater than 28x and even P/E's higher than 53x are not unusual. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's limited.

With earnings growth that's superior to most other companies of late, Jiangsu Yuyue Medical Equipment & Supply has been doing relatively well. It might be that many expect the strong earnings performance to degrade substantially, which has repressed the P/E. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.

big
SZSE:002223 Price to Earnings Ratio vs Industry July 29th 2024
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Jiangsu Yuyue Medical Equipment & Supply.

What Are Growth Metrics Telling Us About The Low P/E?

There's an inherent assumption that a company should underperform the market for P/E ratios like Jiangsu Yuyue Medical Equipment & Supply's to be considered reasonable.

Taking a look back first, we see that the company grew earnings per share by an impressive 26% last year. The latest three year period has also seen a 28% overall rise in EPS, aided extensively by its short-term performance. Therefore, it's fair to say the earnings growth recently has been respectable for the company.

Turning to the outlook, the next three years should generate growth of 6.5% each year as estimated by the ten analysts watching the company. Meanwhile, the rest of the market is forecast to expand by 24% per annum, which is noticeably more attractive.

In light of this, it's understandable that Jiangsu Yuyue Medical Equipment & Supply's P/E sits below the majority of other companies. Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.

The Final Word

Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.

As we suspected, our examination of Jiangsu Yuyue Medical Equipment & Supply's analyst forecasts revealed that its inferior earnings outlook is contributing to its low P/E. Right now shareholders are accepting the low P/E as they concede future earnings probably won't provide any pleasant surprises. It's hard to see the share price rising strongly in the near future under these circumstances.

Having said that, be aware Jiangsu Yuyue Medical Equipment & Supply is showing 2 warning signs in our investment analysis, you should know about.

Of course, you might also be able to find a better stock than Jiangsu Yuyue Medical Equipment & Supply. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする